None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients belonging to ASA I and II Patients willing to give informed consent
Exclusion criteria
Exclusion criteria: Patient not willing to give informed consent Patients with uncontrolled diabetes, hypertension, cardiovascular, respiratory, renal, hepatic , endocrine disorders Patients with neurological and psychiatric disturbances Patients with history of drug allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume (ml) of isoflurane consumptionTimepoint: Volume (ml) of isoflurane consumption will be noted intraoperatively every half hour till the end of surgery and total consumption at the end of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Effect of oral tizanidine on preoperative and early post operative sedation 2)Safety profile of oral tizanidineTimepoint: 1)sedation using Ramsay sedation scale is recorded every 15 minutes after drug is administered till the patient is taken up for surgery. also post operatively every 15 minutes for first half hour, then every 30 minutes for 2 hours and then every hour for 6 hours 2)side effects will be assessed preoperatively from when drug is administered, intraoperatively and post operatively for 6 hours | — |
Countries
India
Contacts
Bangalore Medical College and Research Institute